Vestura
Product Images NDC 0093-4000

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Vestura (NDC 0093-4000). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 1)

The text consists of a list of studies with their hazard ratio, rate ratio, and odds ratio. The studies include Ingenix, EURAS, LASS, an FDA-funded study, a Danish study, a Danish re-analysis, MEGA study, German case-control, PharMetrics, and GPRD study. There is no additional information available.*

FDA Label Image

Figure 2 (Image 2)

FDA Label Image

Structural Formula (Image 3)

FDA Label Image

Chart (Image 4)

This is a list of various methods of birth control and their efficacy rates. The efficacy rates are provided in terms of the number of pregnancies per 100 women in one year for each method. The methods listed include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during the most fertile days of the monthly cycle, spermicide, and withdrawal. The efficacy rates vary greatly between the different methods.*

FDA Label Image

Blister (Image 5)

FDA Label Image

Likelihood Of Developing A Serious Blood Clot (Image 6)

This text provides information regarding the likelihood of developing a serious blood clot. It shows ranges for women who are non-pregnant and non-COC users, women who use COC, and women who are pregnant (only up to 12 weeks). The data is presented as the number of women with a blood clot out of 10,000 Women Years. The rate of blood clot occurrence for pregnant women is based on the actual duration of pregnancy and the assumed pregnancy duration of nine months.*

FDA Label Image

Carton (Image 7)

Vestura tablets are oral contraceptives that contain drospirenone and ethinyl estradiol to prevent pregnancy. This medication does not protect against HIV infection or other sexually transmitted diseases. It comes in 3 mg/0.02 mg, with each package containing 28 tablets. The product code is NDC 0093-4000-62.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.